Generated Narrative
Resource "cfsb1641383289499" (Language "en")
status: final
type: Package Leaflet (#100000155538)
date: 2015-02-07T13:28:17Z
author: See above (Organization/cfsb1640870284639)
title: TEST PURPOSES ONLY - Humalog Vulcan ePI
confidentiality: U
Always use Humalog Mix50 exactly as your doctor has told you. You should check with your doctor if you are not sure. To prevent the possible transmission of disease, each cartridge must be used by you only, even if the needle on the delivery device is changed.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Before the first use store your Humalog Mix50 in a refrigerator (2°C – 8°C). Do not freeze.
Keep your cartridge in use at room temperature (below 30°C) and discard after 28 days. Do not put it near heat or in the sun. Do not keep your pen or the cartridges you are using in the fridge. The pen with the inserted cartridge should not be stored with the needle attached.
Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the label and the carton. The expiry date refers to the last day of that month.
Do not use this medicine if you notice clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. Check each time you inject yourself. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance is insulin lispro. Insulin lispro is made in the laboratory by a ‘recombinant DNA technology’ process. It is a changed form of human insulin and so is different from other human and animal insulins. Insulin lispro is closely related to human insulin which is a natural hormone made by the pancreas. The other ingredients are protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium phosphate 7H2O, zinc oxide and water for injection. Sodium hydroxide or hydrochloric acid may have been used to adjust the acidity.
Generated Narrative
Resource "cfsb1640870284639"
identifier: id: ORG-100000426 (OFFICIAL)
active: true
type: Marketing authorisation holder (#220000000034)
name: Eli Lilly Nederland B.V.
address: Papendorpseweg 83, 3528 BJ Utrecht The Netherlands(WORK)
Generated Narrative
Resource "cfsb1641381635293"
identifier: id: ORG-100000156 (OFFICIAL)
active: true
type: Manufacturer API (#/#220000000033)
name: Eli Lilly and Company
address: Lilly Technology Center Building 333 and 324(WORK)
Generated Narrative
Resource "cfsb1640870328895"
identifier: id: ORG-100003996 (OFFICIAL)
active: true
type: manufacturer (#/#220000000033)
name: Lilly S.A.
address: Avenida de la Industria 30(WORK)
Generated Narrative
Resource "cfsb1640870220343"
identifier: id: EU/1/96/007/035 (OFFICIAL)
subject: See above (MedicinalProductDefinition/cfsb1641212233583)
type: Marketing Authorisation (#/#100000072062)
region: European Union (unknown#eu)
status: Active (PublicationStatus#active)
statusDate: 2015-02-07T13:28:17Z
Generated Narrative
Resource "cfsb1641212233583"
type: Marketing Authorisation (#/#100000072062)
domain: Human use (#/#100000000012)
status: Active (PublicationStatus#active)
legalStatusOfSupply: Medicinal product subject to medical prescription (#/#100000072084)
name
productName: Humalog Mix50 Insulin KwikPen, 3ml pre-fill
type: Full name (#/#220000000001)
NameParts
- Part Type * Suspension for injection Pharmaceutical dose form part (#/#220000000005) CountryLanguages
- Country Jurisdiction Language * European Union (unknown#eu) European Union (unknown#eu) English (Tags for the Identification of Languages#en)
Generated Narrative
Resource "cfsb1640781499340"
identifier: id: EU/1/96/007/035 (OFFICIAL)
name: Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen
type: Chemical Medininal Prodcut (#/#100000155527)
packageFor: See above (MedicinalProductDefinition/cfsb1641212233583)
status: Active (PublicationStatus#active)
statusDate: 2015-02-07T13:28:17Z
containedItemQuantity: 3 ml
manufacturer:
- | Type | Quantity | Material |
* | Pre-filled pen (##100000073543) | 5 | Glass type 1 (##200000003204) |
Generated Narrative
Resource "cfsb1640606978608"
status: active
formOf: See above (MedicinalProductDefinition/cfsb1641212233583)
administrableDoseForm: Suspension for injection (#/#100000073864)
unitOfPresentation: Pen (#/#200000002135)
producedFrom: See above (ManufacturedItemDefinition/cfsb1640777487408)
routeOfAdministration
code: Subcutaneous use (#/#100000073633)
TargetSpecies
- Code * Human (#/#100000109093)
Generated Narrative
Resource "cfsb1640777487408"
identifier: id: EU/1/96/007/035 (OFFICIAL)
status: active
manufacturedDoseForm: Suspension for injection (#100000073864)
unitOfPresentation: Pen (#/#200000002135)
manufacturer: See above (Organization/cfsb1640870328895)
Generated Narrative
Resource "cfsb1640607635665"
identifier: id: GFX7QIS1II (OFFICIAL)
status: active
role: active (#00000072072)
- | Manufacturer |
* | See above (Organization/cfsb1641381635293) |
substance
Strengths
- Presentation[x] Basis * 100 units/ml active ingredient - basis of strength (v3-RoleClassIngredientEntity#ACTIB)
Generated Narrative
Resource "cfsb1640780048702"
identifier: id: PDC6A3C0OX (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance
Generated Narrative
Resource "cfsb1640780784213"
identifier: id: QTT17582CB (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance
Generated Narrative
Resource "cfsb1640780830373"
identifier: id: 55X04QC32I (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance
Generated Narrative
Resource "cfsb1640780743829"
identifier: id: 059QF0KO0R (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance
Generated Narrative
Resource "cfsb1640780625902"
identifier: id: SOI2LOH54Z (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance
Generated Narrative
Resource "cfsb1640780419325"
identifier: id: GGO4Y809LO (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance
Generated Narrative
Resource "cfsb1640780546710"
identifier: id: 023C2WHX2V (OFFICIAL)
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1640870328895) |
substance